SCHEMBL11301136

SCHEMBL11301136

COC(=O)c1ccc(N(CC(C)c2ccccc2)C2CCNC2=O)cc1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 1/20 0.42
▸ OPRD1 P41143 3/20 0.42
▸ ALDH1A1 P00352 4/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ GAA P10253 1/20 0.40
▸ MAPT P10636 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ CCR5 P51681 2/20 0.38
▸ TSHR P16473 2/20 0.37
▸ MAPK1 P28482 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ TAAR1 Q96RJ0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11301466 0.88 HDAC1 (0.44) ALDH1A1MAPK1
SCHEMBL11296058 0.80 MEN1 (0.47) ROCK2OPRD1ALDH1A1L3MBTL1GAA
SCHEMBL11301119 0.79 MAPT (0.40) ROCK2OPRD1ALDH1A1MAPTRAB9A
SCHEMBL11300531 0.77 HDAC1 (0.42) —
SCHEMBL11301107 0.74 TDP1 (0.36) ROCK2OPRD1ALDH1A1L3MBTL1GAA
SCHEMBL11295039 0.72 PSEN1 (0.40) GAAKMT2ATSHRSMN1; SMN2
SCHEMBL11299441 0.71 MAPK14 (0.37) OPRD1L3MBTL1GAAMAPTMEN1
SCHEMBL11296532 0.69 SLC6A3 (0.40) OPRD1ALDH1A1L3MBTL1GAAMAPT
SCHEMBL11296506 0.69 ALOX15 (0.44) ALDH1A1L3MBTL1RAB9ATSHRHTT
SCHEMBL11299544 0.68 HDAC1 (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback